← Browse by Condition
Medical Condition

relapsed or refractory lymphomas

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06132503 Phase 1
Recruiting

Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors

Enrollment
110 pts
Location
United States
Sponsor
Lantern Pharma Inc.
View Trial →